For the final week of #MyelomaActionMonth Ingress is proud to highlight its methodological publication on extrapolating survival data of multiple myeloma patients which was referenced in NICE DSU Technical Support Document 21!

In this study, our colleagues Mahmoud Hashim and Bart Heeg collaborated to demonstrate how clinical trial data can be extrapolated using historical trial data–based a priori distributions.

They presented a Bayesian approach with informative a priori distributions for the shape parameter that improved the survival extrapolations. This approach may be valuable for HTAs that deal with immature data.

Read the full publication at:


Geen alternatieve tekst opgegeven voor deze afbeelding